External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation

Academic Article
Publication Date:
2022
Short description:
External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation / Franco, P., Porreca, A., Mantello, G., Valvo, F., Gasparini, L., Slim, N., Manfrida, S., De Felice, F., Gerardi, M.A., Vagge, S., Krengli, M., Palazzari, E., Osti, M.F., Gonnelli, A., Catalano, G., Pittoni, P., Ivaldi, G.B., Lupattelli, M., Rosetto, M.E., Niespolo, R.M., et al.. - In: RADIOTHERAPY AND ONCOLOGY. - ISSN 0167-8140. - 177:(2022), pp. 9-15. [10.1016/j.radonc.2022.10.015]
abstract:
A prognostic scoring system based on laboratory inflammation parameters, [Hemo-Eosinophils-Inflammation (HEI) index], including baseline hemoglobin level, the systemic inflammatory index and eosinophil count was recently proposed in patients with squamous cell carcinoma of the anus (ASCC). HEI was shown to discriminate disease-free (DFS) and overall (OS) survival in ASCC patients treated with concurrent chemoradiation (CRT). We tested the accuracy of the model on a multicentric cohort for external validation.
Iris type:
1.1 Articolo in rivista
Keywords:
Anal cancer; Concurrent Chemo-radiation; Hemo-Eosinophils-Inflammation Index; Prognosis; Radiotherapy
List of contributors:
Authors of the University:
Handle:
https://iris.unisr.it/handle/20.500.11768/184296
Published in:
RADIOTHERAPY AND ONCOLOGY
Journal
RADIOTHERAPY AND ONCOLOGY
Series